Europital launches as science-driven full service CRO

Ghent (Belgium), 22 September 2020: Europital – a globally-focussed full service CRO serving small and mid-tier innovators – announces a significant expansion as it launches new capabilities across project management, clinical monitoring, biostatistics, pharmacovigilance, regulatory affairs and data management. The expanded clinical research offering will see Europital support clients as a full service CRO in over 40 countries from IND through to commercial launch.

We are delighted to announce that we can now provide a full, 360-degree CRO service to innovators in the pharmaceutical, biotechnology and medical devices sectors. Europital has seen robust expansion in the last few years and we have been preparing to launch full-service capabilities. It’s no secret, there is a large gap in the CRO industry for these small innovators; what they need is a science-driven CRO that will support them closely with an experienced senior team, but combined with a global trial network. We’re very excited to be able to further support our current partners and many of the new innovators bringing vital therapies to patients,” commented Dr. Mohamed El Malt, CEO and Chief Medical Officer of Europital.

Europital has regional offices in Belgium, Hungary and in the UK and customers are based in both in Europe and Unites States. Innovators with therapies under development in therapeutic areas spanning oncology, infectious diseases, inflammatory and autoimmune diseases, and immunology will be major beneficiaries of the company’s multi-functional and operational capabilities. In particular, sponsors that require global CRO services for complex molecules and trial structures that necessitate senior medical and scientific oversight.

In addition to Europe, the company has built a trusted partner network over the last 10-years, with preferential supply trial site agreements and local operational expertise in the USA, Canada, Russia, India, the MENA region and Australasia.

The difference we bring to sponsors is that our senior teams stay with trials from contract to commercialisation – you get the same senior, experienced team. As a science based CRO we provide deep therapeutic medical knowledge and a track record of delivery. The decision to launch as a full service CRO reflects the many requests we have had from our client base over the past few years to work on other aspects of their clinical trials, which we previously had to turn away. But now we are able to support them throughout the whole trial process. Our goal now is to further build our partnerships as the leading science-based CRO for small pharma and biotech companies,” added Dr. El Malt.



About Europital

Europital is a Global provider of Medical Management services during Clinical Research and Drug Development phases working for the pharmaceutical, biotechnology and medical device industries or with Governmental and Scientific Institutes.

The Europital Team delivers all your required Medical Expertise in International Clinical Studies from Study Design until the Final Clinical Study Report, including Medical Oversight, 24/7 Medical Monitoring and support to study teams, and Medical Review of documents and data. Our team also provides Full Medical Writing Services, in addition to Pharmacovigilance consultancy and Training and Development services.

With our scientific mindset, procedural approach and creative solutions, our team is dedicated to quality services with a high sense of project ownership. With our team readiness, reliability and flexibility, we are committed to the success of your project.

Back to news